Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Non-alcoholic fatty liver disease (NAFLD) prevalence in Latin American and the Caribbean: Protocol for a systematic review

Yesmi Arcelia Ortega Rojas, Claudia Lucía Vidal Cuéllar, Karina Mercedes Aparicio Barrón, Rodrigo Carrillo Larco
doi: https://doi.org/10.1101/2020.11.16.20232744
Yesmi Arcelia Ortega Rojas
1School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Perú
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Lucía Vidal Cuéllar
1School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Perú
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karina Mercedes Aparicio Barrón
1School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Perú
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rodrigo Carrillo Larco
2CRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia
3Department of Epidemiology and Biostatistics, Imperial College of London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rodrigo.carrillo{at}upch.pe
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Non-alcoholic fatty liver disease (NAFLD) is the most common worldwide cause of chronic liver disease and it carries a significant economic burden for the healthcare system. The worldwide prevalence of NAFLD appears to be 25%, with the highest rates in Latin America and the Caribbean (LAC) and the middle west. Prevalence of NAFLD in LAC has not been well represented in multiple global meta-analyses because they did not include regional search engines or excluded papers in Spanish. Furthermore, older estimates may not represent the current epidemiological situation given the recent rise of several risk factors like obesity, unhealthy diet and lifestyles in LAC.

Objective To estimate the prevalence of NAFLD in the general adult population of LAC.

Methods Systematic review and meta-analysis. We will conduct a search in OVID (MEDLINE, Embase, Global Health), Cochrane Library, and LILACS. Search terms include those related to non-alcoholic fatty liver disease, along with countries in LAC. We seek observational studies with a random sample of the general population, closed populations, and patients; results will be presented for each of these groups. Titles and abstracts will be screened by two reviewers independently. After the screening phase, we will download the full-text of the selected publications and two reviewers will comprehensively read these papers. If there is any discrepancy in any of these two selection phases, it will be solved by consensus by the two reviewers or by a third party. An extraction data form in a spreadsheet will be developed and tested with a random sample of five selected studies. The data extracted will include study details, sample size, method of NAFLD diagnosis and prevalence of NAFLD. Data extraction will be conducted by two reviewers independently. We will use the risk of bias tool proposed by Hoy and colleagues. We will report the main features of the selected reports in tables, this will include the prevalence estimates. We will pool the prevalence estimates. We will only conduct the meta-analysis if there are three or more individual estimates and there is not large heterogeneity amongst them. We will conduct all statistical analyses using Stata 16.0

Conclusions This systematic review and meta-analysis will provide updated evidence about the prevalence of NAFLD in LAC. Thereby, we will increase NAFLD awareness as a public health problem in LAC, and our results can inform strategies and interventions to reduce NAFLD burden in LAC. We will also pinpoint research needs and discuss future steps so that more robust evidence about NAFLD becomes available in LAC.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Rodrigo M Carrillo-Larco is supported by a Wellcome Trust International Training Fellowship (214185/Z/18/Z).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This is a systematic review protocol. No human subjects were involved in this project. Thus, this study was classified as non-human subject research. Therefore, no approval was needed from an IRB/ethics committee

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

This is a systematic review protocol, and no data have been analysed.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted November 18, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Non-alcoholic fatty liver disease (NAFLD) prevalence in Latin American and the Caribbean: Protocol for a systematic review
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Non-alcoholic fatty liver disease (NAFLD) prevalence in Latin American and the Caribbean: Protocol for a systematic review
Yesmi Arcelia Ortega Rojas, Claudia Lucía Vidal Cuéllar, Karina Mercedes Aparicio Barrón, Rodrigo Carrillo Larco
medRxiv 2020.11.16.20232744; doi: https://doi.org/10.1101/2020.11.16.20232744
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Non-alcoholic fatty liver disease (NAFLD) prevalence in Latin American and the Caribbean: Protocol for a systematic review
Yesmi Arcelia Ortega Rojas, Claudia Lucía Vidal Cuéllar, Karina Mercedes Aparicio Barrón, Rodrigo Carrillo Larco
medRxiv 2020.11.16.20232744; doi: https://doi.org/10.1101/2020.11.16.20232744

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Gastroenterology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)